ATE206416T1 - Trizyklische verbindungen als matrix- metalloproteinase inhibitoren - Google Patents

Trizyklische verbindungen als matrix- metalloproteinase inhibitoren

Info

Publication number
ATE206416T1
ATE206416T1 AT96913185T AT96913185T ATE206416T1 AT E206416 T1 ATE206416 T1 AT E206416T1 AT 96913185 T AT96913185 T AT 96913185T AT 96913185 T AT96913185 T AT 96913185T AT E206416 T1 ATE206416 T1 AT E206416T1
Authority
AT
Austria
Prior art keywords
tricyclic compounds
matrix metalloproteinase
metalloproteinase inhibitors
gelatinase
inhibitors
Prior art date
Application number
AT96913185T
Other languages
English (en)
Inventor
Donald Hupe
Linda Lea Johnson
Joseph Armand Picard
Andrew David White
Qi-Zhuang Ye
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/460,437 external-priority patent/US5627206A/en
Priority claimed from US08/460,436 external-priority patent/US5665764A/en
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE206416T1 publication Critical patent/ATE206416T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Furan Compounds (AREA)
AT96913185T 1995-06-02 1996-04-26 Trizyklische verbindungen als matrix- metalloproteinase inhibitoren ATE206416T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/460,437 US5627206A (en) 1995-06-02 1995-06-02 Tricyclic inhibitor of matrix metalloproteinases
US08/460,436 US5665764A (en) 1995-06-02 1995-06-02 Tricyclic inhibitors of matrix metalloproteinases
PCT/US1996/005830 WO1996038434A1 (en) 1995-06-02 1996-04-26 Tricyclic inhibitors of matrix metalloproteinases

Publications (1)

Publication Number Publication Date
ATE206416T1 true ATE206416T1 (de) 2001-10-15

Family

ID=27039692

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96913185T ATE206416T1 (de) 1995-06-02 1996-04-26 Trizyklische verbindungen als matrix- metalloproteinase inhibitoren

Country Status (13)

Country Link
EP (1) EP0828726B1 (de)
JP (1) JPH11506097A (de)
KR (1) KR19990022171A (de)
AT (1) ATE206416T1 (de)
AU (1) AU717570B2 (de)
CA (1) CA2220040A1 (de)
DE (1) DE69615680T2 (de)
DK (1) DK0828726T3 (de)
ES (1) ES2165496T3 (de)
MX (1) MX9708728A (de)
PT (1) PT828726E (de)
WO (1) WO1996038434A1 (de)
ZA (1) ZA964508B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6624177B1 (en) 1996-09-04 2003-09-23 Warner-Lambert Company Matrix metalloproteinase inhibitors and their therapeutic uses
CA2256631A1 (en) 1996-09-04 1998-03-12 Warner-Lambert Company Compounds for and a method of inhibiting matrix metalloproteinases
KR20000068414A (ko) * 1996-09-04 2000-11-25 로즈 암스트롱, 크리스틴 에이. 트러트웨인 매트릭스 메탈로프로테이나제 억제제 및 그의 치료적 용도
EP1028716A1 (de) * 1996-12-09 2000-08-23 Warner-Lambert Company Methoden zur behandlung von herzversagen und ventrikelerweiterung
EP1366765A1 (de) * 1996-12-17 2003-12-03 Warner-Lambert Company Llc VerWendung von Matrix-Metalloproteinase Inhibitoren zur Behandlung von neurologischen Erkrankungen und zur Förderung der Wundheilung
AU737117B2 (en) * 1996-12-17 2001-08-09 Warner-Lambert Company Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing
WO1999018079A1 (en) * 1997-10-06 1999-04-15 Warner-Lambert Company Heteroaryl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
AU4229499A (en) 1998-07-30 2000-02-21 Warner-Lambert Company Tricyclic heteroaromatics and their derivatives as inhibitors of matrix metalloproteinases
NZ509439A (en) 1998-07-30 2002-10-25 Warner Lambert Co Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
DOP2002000334A (es) * 2001-02-14 2002-08-30 Warner Lambert Co Pirimidinas biciclicas como inhibidores de metaloproteinasas de matriz
AU2003253150A1 (en) * 2002-08-13 2004-02-25 Warner-Lambert Company Llc Chromone derivatives as matrix metalloproteinase inhibitors
BRPI0715231A2 (pt) * 2006-08-22 2013-06-25 Ranbaxy Lab Ltd compostos, composiÇÕes farmacÊuticas e seus usos, auxiliar quiral e seu uso e processos para preparar um composto

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3649651A (en) * 1969-07-02 1972-03-14 American Home Prod Dibenzofuran derivatives and preparation thereof
US5326760A (en) * 1992-06-29 1994-07-05 Glaxo, Inc. Aminobutanoic acid compounds having metalloprotease inhibiting properties

Also Published As

Publication number Publication date
WO1996038434A1 (en) 1996-12-05
MX9708728A (es) 1997-12-31
DE69615680T2 (de) 2002-07-11
DK0828726T3 (da) 2002-01-21
PT828726E (pt) 2002-03-28
AU717570B2 (en) 2000-03-30
EP0828726A1 (de) 1998-03-18
ZA964508B (en) 1996-12-09
ES2165496T3 (es) 2002-03-16
AU5577796A (en) 1996-12-18
DE69615680D1 (de) 2001-11-08
EP0828726B1 (de) 2001-10-04
KR19990022171A (ko) 1999-03-25
CA2220040A1 (en) 1996-12-05
JPH11506097A (ja) 1999-06-02

Similar Documents

Publication Publication Date Title
IL123901A (en) Sulfonamide inhibitors of matrix metalloproteinases and pharmaceutical compositions comprising them
ATE214368T1 (de) Aromatische keto-säure und ihre derivate als inhibitoren der matrix metalloproteinase
DE69615680D1 (de) Trizyklische verbindungen als matrix-metalloproteinase inhibitoren
Kivelä‐Rajamäki et al. Levels and molecular forms of MMP‐7 (matrilysin‐1) and MMP‐8 (collagenase‐2) in diseased human peri‐implant sulcular fluid
NZ509439A (en) Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
DK0398753T3 (da) Metalloproteinasehæmmer
FI953139A0 (fi) Atovakonia käsittäviä farmaseuttisia koostumuksia
NO944448D0 (no) Nye farmasöytiske anvendelser av krill-enzymer
DE69824748D1 (de) Pharmazeutische zusammensetzung für die behandlung von enzündlichen darmerkrankungen
BR0013390A (pt) Compostos de ácido hidroxâmico úteis como inibidores de metaloproteinase de matriz
NO20000771L (no) Anvendelse av fankinon for behandling av Alzheimers sykdom
DE69303234D1 (de) Behandlung von entzündlichen Darmerkrankungen
CA2233560A1 (en) Sulfonamide inhibitors of matrix metalloproteinases
FR2707166B1 (fr) Utilisation de l'efaroxan et de ses dérivés pour la fabrication de médicaments destinés au traitement de maladies neurodégénératives et leur progression .
ATE240290T1 (de) Verbindungen verwendbar für die behandlung von allergien und entzündungskrankheiten
FR2691360B1 (fr) Compositions pharmaceutiques destinees en particulier au traitement des poches parondontales et procede de fabrication.
ES2101982T3 (es) Composicion conteniendo una alta dosis de vitamina a.
EA199800372A1 (ru) Новые макроциклические соединения-ингибиторы

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee